Form 4: Guardant Health Executive Kumud Kalia Reports Stock Transactions
SEC Form 4 Filing
Guardant Health's Chief Information Officer, Kumud Kalia, reported the vesting of restricted stock units and subsequent tax withholding transactions.
Summary
- Kumud Kalia, Chief Information Officer of Guardant Health, reported transactions involving company stock on December 15, 2024.
- These transactions include the vesting of 637 restricted stock units and the subsequent withholding of 323 shares to cover tax obligations.
- The vesting of the restricted stock units was part of an award granted on June 9, 2023, which vests over a three-year period.
- Following these transactions, Kalia directly owns 18,408 shares of Guardant Health common stock and 3,824 restricted stock units.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and does not indicate any significant positive or negative sentiment. It is a routine filing.
Positives
- The vesting of restricted stock units indicates a continued alignment of executive interests with the company's performance.
- The tax withholding process ensures compliance with tax regulations.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It provides transparency into the stock transactions of company insiders.
Comparison to Industry Standards
- The vesting schedule of the restricted stock units, with a three-year vesting period and quarterly installments, is a common practice in the technology and biotech industries.
- Tax withholding practices are standard for equity compensation to ensure compliance with tax regulations.
- Similar filings are regularly made by executives at comparable companies such as Exact Sciences and Illumina.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
- The tax withholding ensures compliance and does not negatively impact the company's financial position.
Key Dates
| Date | Description |
|---|---|
| 2023-06-09 | Date of the restricted stock unit award grant. |
| 2024-06-15 | Date when 33% of the restricted stock units vested. |
| 2024-12-15 | Date of the reported stock transactions, including vesting and tax withholding. |
| 2024-12-16 | Date the Form 4 was signed. |
Keywords
Guardant Health, stock transaction, restricted stock units, executive compensation, Form 4, insider trading, Kumud Kalia, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.